306 related articles for article (PubMed ID: 2642725)
1. Clinical applications of recombinant human colony-stimulating factors.
Klingemann HG
CMAJ; 1989 Jan; 140(2):137-42. PubMed ID: 2642725
[TBL] [Abstract][Full Text] [Related]
2. [GM-CSF and G-CSF: cytokines in clinical application].
Ruef C; Coleman DL
Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
[TBL] [Abstract][Full Text] [Related]
3. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
[TBL] [Abstract][Full Text] [Related]
4. The clinical use of hematopoietic growth factors.
Appelbaum FR
Semin Hematol; 1989 Jul; 26(3 Suppl 3):7-14. PubMed ID: 2477905
[TBL] [Abstract][Full Text] [Related]
5. The clinical use of colony stimulating factors.
Moore MA
Annu Rev Immunol; 1991; 9():159-91. PubMed ID: 1910675
[TBL] [Abstract][Full Text] [Related]
6. Future strategies in the control of myelosuppression: the use of colony-stimulating factors.
Haeuber D
Oncol Nurs Forum; 1991 Mar; 18(2 Suppl):16-21. PubMed ID: 2047296
[TBL] [Abstract][Full Text] [Related]
7. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
8. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
9. Clinical applications of colony-stimulating factors.
Vadhan-Raj S
Oncol Nurs Forum; 1989; 16(6 Suppl):21-6. PubMed ID: 2687811
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.
Vadhan-Raj S; Keating M; LeMaistre A; Hittelman WN; McCredie K; Trujillo JM; Broxmeyer HE; Henney C; Gutterman JU
N Engl J Med; 1987 Dec; 317(25):1545-52. PubMed ID: 3500414
[TBL] [Abstract][Full Text] [Related]
11. Colony-stimulating factors: clinical applications.
Blackwell S; Crawford J
Pharmacotherapy; 1992; 12(2 Pt 2):20S-31S. PubMed ID: 1598311
[TBL] [Abstract][Full Text] [Related]
12. Clinical applications of human granulocyte-macrophage colony-stimulating factor.
Sakamoto KM; Gasson JC
Int J Cell Cloning; 1991 Nov; 9(6):531-41. PubMed ID: 1770227
[TBL] [Abstract][Full Text] [Related]
13. [Current status of the clinical application of hematopoietic growth factors in oncology].
Karthaus M; Ganser A
Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
[TBL] [Abstract][Full Text] [Related]
14. The promise of colony-stimulating factors in clinical practice.
Glaspy JA; Ambersley JM
Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043
[TBL] [Abstract][Full Text] [Related]
15. Clinical role of granulocyte-macrophage colony-stimulating factor.
Mitsuyasu RT; Golde DW
Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
[TBL] [Abstract][Full Text] [Related]
16. A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.
Rifkin RM; Hersh EM; Salmon SE
Behring Inst Mitt; 1988 Aug; (83):125-33. PubMed ID: 3071327
[TBL] [Abstract][Full Text] [Related]
17. Colony stimulating factors.
Klingemann HG; Eaves CJ
Bone Marrow Transplant; 1988 May; 3(3):177-84. PubMed ID: 2458788
[TBL] [Abstract][Full Text] [Related]
18. [Colony-stimulating factors. Therapeutic applications].
Kusminsky GD; Koziner B
Sangre (Barc); 1990 Oct; 35(5):381-7. PubMed ID: 2291148
[No Abstract] [Full Text] [Related]
19. G-CSF and GM-CSF in clinical trials.
Antman KH
Yale J Biol Med; 1990; 63(5):387-410. PubMed ID: 1705737
[TBL] [Abstract][Full Text] [Related]
20. Dose escalation study of recombinant human granulocyte-colony-stimulating factor (KRN8601) in patients with advanced malignancy.
Eguchi K; Sasaki S; Tamura T; Sasaki Y; Shinkai T; Yamada K; Soejima Y; Fukuda M; Fujihara Y; Kunitou H
Cancer Res; 1989 Sep; 49(18):5221-4. PubMed ID: 2475245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
